论文部分内容阅读
药品平行进口作为药品专利权归属与药品可及性之间的平衡点,一方面使药品可及性得到了增加,促进了对国内公共健康权的保护,另一方面由于其在一定程度上损害了制药公司的利益,而备受国际社会争议。文章通过对TRIPS协议的分析,阐明了对我国药品平行进口的基本态度,以及我国如何在TRIPS协议框架下实施药品平行进口的问题。
As a balance between the ownership of pharmaceuticals and the accessibility of medicines, parallel imports of medicines increase the availability of medicines, promote the protection of the public health right in the country and, to a certain extent, damage The interests of pharmaceutical companies, but much controversy in the international community. Through the analysis of the TRIPS agreement, the article clarifies the basic attitude towards the parallel importation of pharmaceuticals in our country and how to implement the parallel importation of pharmaceuticals under the TRIPS agreement in our country.